Canada - English - Health Canada

abri pharmaceuticals inc - diclofenac sodium; misoprostol - tablet (enteric-coated) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Australia - English - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - diclofenac sodium, quantity: 10 mg/g - gel - excipient ingredients: carbomer 980; lecithin; octyldodecanol; ammonia; decyl oleate; purified water; disodium edetate; d-alpha-tocopherol; isopropyl alcohol; fragrance (perfume) - short term (up to 2 weeks) local symptomatic treatment of the following musculoskeletal inflammatory conditions: a) acute soft tissue injuries, including sprains, tendinitis and sports injury; b) localised forms of soft tissue rheumatism e.g. tendinitis and bursitis.

Kenya - English - Pharmacy and Poisons Board

kremoint pharma pvt. ltd. b-8, additional ambernath, m.i.d.c., ambernath - methyl salicylate bp, diclofenac diethylamine bp,… - gel - methyl salicylate bp 10.00 % w/w, diclofenac… - peripherally acting muscle relaxants:

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diclofenac sodium 100mg - modified release tablet - 100 mg - active: diclofenac sodium 100mg excipient: dextrates hyetellose hypromellose iron oxide red iron oxide yellow macrogol 3350 magnesium stearate microcrystalline cellulose titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diclofenac sodium 75mg - modified release tablet - 75 mg - active: diclofenac sodium 75mg excipient: carnauba wax dextrates hyetellose hypromellose iron oxide red macrogol 3350 magnesium stearate microcrystalline cellulose purified water titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - diclofenac potassium - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

focus pharmaceuticals ltd - diclofenac potassium - oral tablet - 50mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

galentic pharma (india) private limited, india - diclofec , methyl salicylate , eucalyptus oil ,mephenesin ,capsaicin - gel - diclofenac diethylammonium 1.16 % + oleum lini 3 % + methyl salicylate 10 % + menthol 5

Ireland - English - HPRA (Health Products Regulatory Authority)

norton waterford - diclofenac sodium - tablets - 25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

norton waterford - diclofenac sodium - tablets - 50 milligram